{"id":"https://openalex.org/W4397012847","doi":"https://doi.org/10.1158/1557-3265.bladder24-a010","title":"Abstract A010: Cancer associated fibroblast dependency in a novel immunocompetent mouse model of bladder cancer","display_name":"Abstract A010: Cancer associated fibroblast dependency in a novel immunocompetent mouse model of bladder cancer","publication_year":2024,"publication_date":"2024-05-17","ids":{"openalex":"https://openalex.org/W4397012847","doi":"https://doi.org/10.1158/1557-3265.bladder24-a010"},"language":"en","primary_location":{"id":"doi:10.1158/1557-3265.bladder24-a010","doi":"https://doi.org/10.1158/1557-3265.bladder24-a010","is_oa":false,"landing_page_url":"http://dx.doi.org/10.1158/1557-3265.bladder24-a010","pdf_url":null,"source":{"id":"https://openalex.org/S183149254","display_name":"Clinical Cancer Research","issn_l":"1078-0432","issn":["1078-0432","1557-3265"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical Cancer Research","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5011122559","display_name":"Philip H. Abbosh","orcid":"https://orcid.org/0000-0003-3611-9532","observed_orcids":["https://orcid.org/0000-0003-3611-9532"]},"institutions":[{"id":"https://openalex.org/I1289437631","display_name":"Fox Chase Cancer Center","ror":"https://ror.org/0567t7073","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1289437631","https://openalex.org/I4210122924"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Philip H. Abbosh","raw_affiliation_strings":["1Fox Chase, Philadelphia, PA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Fox Chase, Philadelphia, PA","institution_ids":["https://openalex.org/I1289437631"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5026525677","display_name":"Henkel Valentine","orcid":"https://orcid.org/0000-0001-6869-3497","observed_orcids":["https://orcid.org/0000-0001-6869-3497"]},"institutions":[{"id":"https://openalex.org/I1289437631","display_name":"Fox Chase Cancer Center","ror":"https://ror.org/0567t7073","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1289437631","https://openalex.org/I4210122924"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Henkel Valentine","raw_affiliation_strings":["1Fox Chase, Philadelphia, PA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Fox Chase, Philadelphia, PA","institution_ids":["https://openalex.org/I1289437631"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I1289437631"],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"30","issue":"10_Supplement","first_page":"A010","last_page":"A010"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10458","display_name":"Bladder and Urothelial Cancer Treatments","score":0.7577999830245972,"subfield":{"id":"https://openalex.org/subfields/2746","display_name":"Surgery"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10458","display_name":"Bladder and Urothelial Cancer Treatments","score":0.7577999830245972,"subfield":{"id":"https://openalex.org/subfields/2746","display_name":"Surgery"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10952","display_name":"PI3K/AKT/mTOR signaling in cancer","score":0.14830000698566437,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11501","display_name":"TGF-\u03b2 signaling in diseases","score":0.019500000402331352,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/bladder-cancer","display_name":"bladder cancer","score":0.8450000286102295},{"id":"https://openalex.org/keywords/cancer-associated-fibroblasts","display_name":"cancer-associated fibroblasts","score":0.9129999876022339},{"id":"https://openalex.org/keywords/immunocompetent-mouse-model","display_name":"immunocompetent mouse model","score":0.8849999904632568},{"id":"https://openalex.org/keywords/pi3k-akt-mtor-pathway","display_name":"PI3K/AKT/mTOR pathway","score":0.9419999718666077},{"id":"https://openalex.org/keywords/kinase-inhibitor-sensitivity","display_name":"kinase inhibitor sensitivity","score":0.6420000195503235},{"id":"https://openalex.org/keywords/ipatasertib","display_name":"ipatasertib","score":0.9160000085830688},{"id":"https://openalex.org/keywords/pten","display_name":"PTEN","score":0.5249999761581421},{"id":"https://openalex.org/keywords/9p21-deletion","display_name":"9p21 deletion","score":0.9010000228881836},{"id":"https://openalex.org/keywords/trp53","display_name":"Trp53","score":0.9049999713897705},{"id":"https://openalex.org/keywords/rb1","display_name":"RB1","score":0.6990000009536743},{"id":"https://openalex.org/keywords/tsc1-tsc2","display_name":"TSC1/TSC2","score":0.7680000066757202},{"id":"https://openalex.org/keywords/tumor-microenvironment","display_name":"tumor microenvironment","score":0.6209999918937683},{"id":"https://openalex.org/keywords/m2-macrophages","display_name":"M2 macrophages","score":0.8759999871253967},{"id":"https://openalex.org/keywords/immune-exclusion","display_name":"immune exclusion","score":0.5820000171661377},{"id":"https://openalex.org/keywords/squamous-differentiation","display_name":"squamous differentiation","score":0.6669999957084656},{"id":"https://openalex.org/keywords/tumor-regression","display_name":"tumor regression","score":0.3100000023841858}],"concepts":[{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.8511607646942139},{"id":"https://openalex.org/C19768560","wikidata":"https://www.wikidata.org/wiki/Q320727","display_name":"Dependency (UML)","level":2,"score":0.5256134867668152},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.5055785179138184},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.4700535535812378},{"id":"https://openalex.org/C2780381497","wikidata":"https://www.wikidata.org/wiki/Q463418","display_name":"Fibroblast","level":3,"score":0.4682040810585022},{"id":"https://openalex.org/C2780352672","wikidata":"https://www.wikidata.org/wiki/Q504775","display_name":"Bladder cancer","level":3,"score":0.4524097740650177},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.382245272397995},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.3275676667690277},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.20600974559783936},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.11640536785125732},{"id":"https://openalex.org/C81885089","wikidata":"https://www.wikidata.org/wiki/Q189082","display_name":"Cell culture","level":2,"score":0.11551091074943542},{"id":"https://openalex.org/C41008148","wikidata":"https://www.wikidata.org/wiki/Q21198","display_name":"Computer science","level":0,"score":0.07342597842216492},{"id":"https://openalex.org/C115903868","wikidata":"https://www.wikidata.org/wiki/Q80993","display_name":"Software engineering","level":1,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1158/1557-3265.bladder24-a010","doi":"https://doi.org/10.1158/1557-3265.bladder24-a010","is_oa":false,"landing_page_url":"http://dx.doi.org/10.1158/1557-3265.bladder24-a010","pdf_url":null,"source":{"id":"https://openalex.org/S183149254","display_name":"Clinical Cancer Research","issn_l":"1078-0432","issn":["1078-0432","1557-3265"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical Cancer Research","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.9763000011444092}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4393092675","https://openalex.org/W4362524752","https://openalex.org/W4409636158","https://openalex.org/W7148824121","https://openalex.org/W4282959712","https://openalex.org/W4379983350","https://openalex.org/W4282979247","https://openalex.org/W3033998989","https://openalex.org/W3022878130","https://openalex.org/W3193204732"],"abstract_inverted_index":{"Abstract":[0],"Introduction:":[1],"The":[2],"relationship":[3,360],"between":[4],"genotype":[5,299],"and":[6,64,77,91,103,106,139,213,237,260,343],"phenotype":[7],"in":[8,74,95,114,118,301,361,395],"targeted":[9],"therapy":[10],"has":[11],"proven":[12],"to":[13,69,120,194,224,256,272,292,307,313,366,372,378],"be":[14],"crucial":[15],"for":[16,101,182,324,346,356],"the":[17,27,84,110,121,195,226,280,330,358,408,416],"successful":[18,126,325],"use":[19,367],"of":[20,86,109,197,216,289,327,340,401,407],"most":[21],"kinase":[22,122,350],"inhibitors.":[23],"In":[24,265,318],"bladder":[25,45,85,163,331,341,362,402],"cancer,":[26],"PI3K/AKT/mTOR":[28,52,232],"pathway":[29,53],"is":[30,336,344],"widely":[31],"activated":[32],"by":[33,229,286,349],"mutation":[34],"but":[35],"untargeted.":[36],"Our":[37],"study":[38],"focuses":[39],"on":[40,376,412],"developing":[41],"an":[42],"immunocompetent,":[43],"CRISPR-edited":[44,62],"cancer":[46,65,342,403],"mouse":[47,130,399],"model":[48,149,339,400],"that":[49,180],"mirrors":[50],"common":[51,231],"mutations.":[54],"We":[55,185,221,364],"established":[56,172,187],"effective":[57],"genotype-kinase":[58],"inhibitor":[59,123,311],"pairings":[60],"using":[61],"organoids":[63,94,98],"associated":[66,392],"fibroblasts":[67],"(CAFs)":[68],"create":[70],"a":[71,115,151,170,188,214,275,309,337,354,370,396],"pro-tumorigenic":[72],"environment":[73],"vivo.":[75],"Methods":[76],"Results:":[78],"Urothelial":[79],"cells":[80,134],"were":[81,99,322],"isolated":[82],"from":[83],"Rosa26":[87],"Lox-Stop-Lox-Cas9/GFP":[88],"transgenic":[89],"mice":[90],"grown":[92],"as":[93,284,369],"matrigel.":[96],"These":[97,208],"co-edited":[100],"Trp53":[102,155],"Rb1":[104],"KO,":[105,236],"further":[107],"editing":[108],"Pten":[111],"gene":[112],"resulted":[113,300],"nine-fold":[116],"increase":[117],"sensitivity":[119,306],"ipatasertib.":[124],"Despite":[125],"initial":[127],"engraftment":[128,326],"into":[129,162,240,279,329],"bladder,":[131],"these":[132],"edited":[133,206],"regressed":[135],"before":[136],"tumor":[137],"formation,":[138],"subcutaneous":[140,145,165,178],"injection":[141],"did":[142],"not":[143],"yield":[144],"tumors.":[146],"An":[147],"alternate":[148],"featuring":[150],"9p21":[152],"deletion":[153],"with":[154,169,199,205],"KO":[156,243,247,282,295],"also":[157,222],"displayed":[158,210,254],"similar":[159],"regression":[160],"post-engraftment":[161],"or":[164,333],"injections.":[166],"However,":[167],"co-injection":[168,204],"previously":[171],"CAF":[173,191],"line":[174],"subcutaneously":[175],"yielded":[176],"palpable":[177],"tumors":[179,198,328],"enlarged":[181],"12":[183],"weeks.":[184],"then":[186],"BBN":[189],"bladder-tumor-derived":[190],"line,":[192],"leading":[193],"formation":[196],"squamous":[200],"differentiation":[201],"upon":[202],"intramural":[203],"organoids.":[207],"models":[209],"immune-excluded":[211],"architecture":[212],"predominance":[215],"M2":[217],"over":[218],"M1":[219],"macrophages.":[220],"aimed":[223],"enhance":[225],"model's":[227],"adaptability":[228],"introducing":[230],"mutations,":[233],"specifically":[234],"TSC1/TSC2":[235,246],"Pik3ca":[238,276,314],"hotspots,":[239],"our":[241],"9p21/Trp53":[242,281,294],"model.":[244],"While":[245],"lines":[248],"exhibited":[249],"elevated":[250],"P-S6K":[251],"signaling,":[252],"they":[253],"resistance":[255],"Torin":[257],"1,":[258],"Voxtalisib,":[259],"Everolimus\u2014kinase":[261],"inhibitors":[262,351],"targeting":[263,348],"mTORC1/2.":[264],"parallel,":[266],"we":[267],"employed":[268],"CRISPR-mediated":[269],"homologous":[270],"recombination":[271],"successfully":[273],"introduce":[274],"H1047R":[277],"hotspot":[278],"genotype,":[283],"evidenced":[285],"increased":[287,305],"Phosphorylation":[288],"AKT":[290],"compared":[291,312],"wild-type":[293],"cell":[296],"lines.":[297],"This":[298],"approximately":[302],"80-fold":[303],"selective":[304],"pictilisib,":[308],"PI3K":[310],"WT":[315],"control.":[316],"Conclusions:":[317],"this":[319],"model,":[320],"CAFs":[321],"required":[323],"wall":[332],"subcutaneously.":[334],"BUTU":[335],"customizable":[338],"suitable":[345],"direct":[347],"while":[352],"providing":[353],"platform":[355],"understanding":[357],"genotype-phenotype":[359],"cancer.":[363],"hope":[365],"it":[368],"tool":[371],"develop":[373],"preclinical":[374],"evidence":[375],"which":[377],"base":[379],"precision":[380],"medicine":[381],"clinical":[382],"trials.":[383],"Citation":[384],"Format:":[385],"Philip":[386],"H.":[387],"Abbosh,":[388],"Henkel":[389],"Valentine.":[390],"Cancer":[391,427],"fibroblast":[393],"dependency":[394],"novel":[397],"immunocompetent":[398],"[abstract].":[404],"In:":[405],"Proceedings":[406],"AACR":[409],"Special":[410],"Conference":[411],"Bladder":[413],"Cancer:":[414],"Transforming":[415],"Field;":[417],"2024":[418],"May":[419],"17-20;":[420],"Charlotte,":[421],"NC.":[422],"Philadelphia":[423],"(PA):":[424],"AACR;":[425],"Clin":[426],"Res":[428],"2024;30(10_Suppl):Abstract":[429],"nr":[430],"A010.":[431]},"counts_by_year":[],"updated_date":"2026-07-14T23:27:15.235271","created_date":"2024-05-18T00:00:00"}